Today: 29 April 2026
Browse Category

NASDAQ:NVCR 25 January 2026 - 12 February 2026

NovoCure stock jumps in premarket after FDA clears Optune Pax for pancreatic cancer

NovoCure stock jumps in premarket after FDA clears Optune Pax for pancreatic cancer

NovoCure shares jumped 23% to $12.91 in U.S. premarket trading Thursday after the FDA approved its Optune Pax device for locally advanced pancreatic cancer. The company said this is the first new FDA-approved treatment for the disease in nearly 30 years. In a Phase 3 trial, median overall survival was 16.2 months with Optune Pax plus chemotherapy, compared to 14.2 months with chemotherapy alone.
12 February 2026
·
ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday

ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday

ImmunityBio shares fell 12.1% to $6.45 Friday after the company previewed new data from its Phase 2 glioblastoma trial, with full results due Jan. 31. The stock traded heavily between $7.88 and $6.43. Median overall survival in the study was “not yet reached” as of Jan. 22, with 19 of 23 patients alive. Investors are watching for more details on durability, safety, and trial design.
25 January 2026
·····

Stock Market Today

  • Verisk Analytics Q1 Earnings and Revenues Beat Estimates, Shares Lagging Year-To-Date
    April 29, 2026, 10:21 AM EDT. Verisk Analytics (VRSK) reported Q1 earnings of $1.82 per share, surpassing the Zacks Consensus Estimate of $1.76 and representing a 3.49% earnings surprise. Revenues rose to $782.6 million, also beating expectations. Despite consistent beats over the past four quarters, shares have dropped about 21% year-to-date versus a 4.3% gain in the S&P 500. The stock holds a Zacks Rank #3 (Hold), suggesting performance in line with the market. Investors await management's guidance for clues on future momentum. The Business - Information Services sector ranks in the top 16% of over 250 Zacks industries, indicating potential support amid mixed earnings estimate revisions.

Latest article

Western Digital Stock Jumps Before Earnings as AI Storage Demand Gets a Seagate Boost

Western Digital Stock Jumps Before Earnings as AI Storage Demand Gets a Seagate Boost

29 April 2026
Western Digital shares rose 9.3% to $427.45 Wednesday after Seagate’s quarterly forecast topped estimates and sent storage stocks higher. Seagate shares jumped 16.6%. Seagate projected fourth-quarter revenue of $3.45 billion and non-GAAP earnings of $5 a share. Western Digital will report fiscal third-quarter results after markets close Thursday.
Generac Stock Jumps After Data Center Backlog Forces a 2026 Forecast Reset

Generac Stock Jumps After Data Center Backlog Forces a 2026 Forecast Reset

29 April 2026
Generac Holdings raised its 2026 sales outlook after first-quarter net sales rose 12% and commercial and industrial sales jumped 28% to $510 million, driven by data center demand. Shares climbed 11% after adjusted earnings of $1.80 a share beat estimates. The company now expects full-year net sales growth in the mid-to-high teens percentage range, up from its prior forecast. Generac also increased its adjusted EBITDA margin guidance.
Lemonade Stock Jumps as Q1 Revenue Surge Sharpens Its 2026 Profit Test

Lemonade Stock Jumps as Q1 Revenue Surge Sharpens Its 2026 Profit Test

29 April 2026
Lemonade Inc reported first-quarter revenue of $258 million, up 71% from a year earlier, and narrowed its net loss to $35.8 million, or 47 cents a share. Shares rose 5.6% in premarket trading after results beat estimates. In-force premium climbed 32% to $1.33 billion, with customers up 23% to 3.14 million. The company raised its 2026 outlook and now expects full-year revenue of up to $1.203 billion.
Go toTop